Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness and Safety of Superselective Adrenal Arterial Embolization (SAAE) for Resistant Hypertension: A Randomized, Parallel, Controlled Clinical Trial

NCT05552300 is registered in ClinicalTrials.gov with First Affiliated Hospital of Chengdu Medical College as lead sponsor.

NCT NCT05552300
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05552300 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness and Safety of Superselective Adrenal Arterial Embolization (SAAE) for Resistant Hypertension: A Randomized, Parallel, Controlled Clinical Trial
Lead sponsor
First Affiliated Hospital of Chengdu Medical College
Phase
Not applicable
Overall status
Unknown status
Start date
October 1, 2022
Completion date
March 31, 2025
Enrollment
144 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

resistant hypertension